Should not be given to patients w/ hepatic or severe renal impairment. Do not w/draw abruptly. Contains FD&C yellow #5 (tartrazine) which may cause allergic type reactions (including bronchial asthma) in certain susceptible persons. Should not be used during pregnancy unless clearly necessary. Should not be used during breastfeeding or discontinue breastfeeding during treatment.
Increased prothrombin time in patient who had been stabilized on warfarin. Reports of confusion, irritability & sleep disorder w/ thyroid extr (specifically T3 + T4).